A NOVEL EMULSIFICATION-SOLVENT EXTRACTION TECHNIQUE FOR PRODUCTION OF PROTEIN LOADED BIODEGRADABLE MICROPARTICLES FOR VACCINE AND DRUG-DELIVERY

被引:54
作者
YEH, MK [1 ]
COOMBES, AGA [1 ]
JENKINS, PG [1 ]
DAVIS, SS [1 ]
机构
[1] UNIV NOTTINGHAM,DEPT PHARMACEUT SCI,NOTTINGHAM NG7 2RD,ENGLAND
关键词
POLY(LACTIDE-CO-GLYCOLIDE); OVALBUMIN; EMULSION SOLVENT EVAPORATION EXTRACTION; CONTROLLED RELEASE; MICROPARTICLE; VACCINE;
D O I
10.1016/0168-3659(94)00123-C
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
This paper describes the preparation of poly(lactide-co-glycolide) (PLG) microparticles containing ovalbumin (OVA) as a model antigen, using three different approaches; based on solvent evaporation/extraction techniques. These are respectively: (1) water-in oil-in water (W/O/W), (2) water-in oil-in water-in oil (W/O/W/O),and (3) water-in oil-in oil (W/O/O). The effects of process parameters on particle size, surface morphology, protein entrapment and release properties are presented. The use of methanol as the continuous phase results in a protein entrapment level of approximately 10% (w/w) in 10 mu m microparticles and the microparticles retain good spherical form. This successful use of an organic continuous phase, which is miscible with the polymer solution, offers the prospect of enhancing the protein loading capacity of resorbable polylactide microparticles and of improving the delivery of effective doses of vaccine and therapeutic proteins and peptides. Ovalbumin appears to act as a surfactant in the water-in oil-in oil method. This has implications for protein release and vaccine performance.
引用
收藏
页码:437 / 445
页数:9
相关论文
共 29 条
[1]   DETERMINANTS OF RELEASE RATE OF TETANUS VACCINE FROM POLYESTER MICROSPHERES [J].
ALONSO, MJ ;
COHEN, S ;
PARK, TG ;
GUPTA, RK ;
SIBER, GR ;
LANGER, R .
PHARMACEUTICAL RESEARCH, 1993, 10 (07) :945-953
[2]   ALBUMIN MICROSPHERES AND MICROCAPSULES - METHODOLOGY OF MANUFACTURING TECHNIQUES [J].
ARSHADY, R .
JOURNAL OF CONTROLLED RELEASE, 1990, 14 (02) :111-131
[3]   CHARACTERIZATION OF DRUG-LOADED POLY(D,L-LACTIDE) MICROSPHERES [J].
BENITA, S ;
BENOIT, JP ;
PUISIEUX, F ;
THIES, C .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (12) :1721-1724
[4]   THE PREPARATION AND EVALUATION OF DRUG-CONTAINING POLY(DL-LACTIDE) MICROSPHERES FORMED BY THE SOLVENT EVAPORATION METHOD [J].
BODMEIER, R ;
MCGINITY, JW .
PHARMACEUTICAL RESEARCH, 1987, 4 (06) :465-471
[5]   CONTROLLED DELIVERY SYSTEMS FOR PROTEINS BASED ON POLY(LACTIC GLYCOLIC ACID) MICROSPHERES [J].
COHEN, S ;
YOSHIOKA, T ;
LUCARELLI, M ;
HWANG, LH ;
LANGER, R .
PHARMACEUTICAL RESEARCH, 1991, 8 (06) :713-720
[6]  
ELDRIDGE JH, 1989, CURR TOP MICROBIOL, V146, P59
[7]   BIODEGRADABLE AND BIOCOMPATIBLE POLY(DL-LACTIDE-CO-GLYCOLIDE) MICROSPHERES AS AN ADJUVANT FOR STAPHYLOCOCCAL ENTEROTOXIN-B TOXOID WHICH ENHANCES THE LEVEL OF TOXIN-NEUTRALIZING ANTIBODIES [J].
ELDRIDGE, JH ;
STAAS, JK ;
MEULBROEK, JA ;
TICE, TR ;
GILLEY, RM .
INFECTION AND IMMUNITY, 1991, 59 (09) :2978-2986
[8]   CONTROLLED VACCINE RELEASE IN THE GUT-ASSOCIATED LYMPHOID-TISSUES .1. ORALLY-ADMINISTERED BIODEGRADABLE MICROSPHERES TARGET THE PEYERS PATCHES [J].
ELDRIDGE, JH ;
HAMMOND, CJ ;
MEULBROEK, JA ;
STAAS, JK ;
GILLEY, RM ;
TICE, TR .
JOURNAL OF CONTROLLED RELEASE, 1990, 11 (1-3) :205-214
[9]  
FESSI H, 1986, Patent No. 2608988
[10]  
FLORENCE AT, 1988, CONTROLLED RELEASE D, P163